RAPT Therapeutics (RAPT) Stock Chart & Stock Price History $1.42 -0.04 (-2.41%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.39 -0.03 (-1.77%) As of 03/27/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RAPT Therapeutics Stock Price Performance 5 Day Performance+8.02%1 Month Performance+24.12%3 Month Performance-16.27%6 Month Performance-27.81%Year-To-Date Performance-10.44%1 Year Performance-84.24% Receive RAPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address RAPT Stock Chart for Friday, March, 28, 2025 RAPT Chart by TradingViewRemove Ads RAPT Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2025$1.45$1.42-2.41%$1.46$1.39507,640 shs$186.79 million03/26/2025$1.56$1.45-7.05%$1.57$1.401.13 million shs$191.41 million03/25/2025$1.53$1.56+1.96%$1.57$1.441.47 million shs$205.93 million03/24/2025$1.31$1.53+16.79%$1.54$1.311.50 million shs$172.93 million03/21/2025$1.20$1.31+9.17%$1.35$1.164.67 million shs$172.93 million03/20/2025$1.15$1.20+4.35%$1.21$1.121.38 million shs$158.41 million03/19/2025$1.09$1.15+5.50%$1.16$1.101.41 million shs$40.20 million03/18/2025$1.12$1.09-2.68%$1.14$1.08614,294 shs$38.10 million03/17/2025$1.14$1.12-1.75%$1.16$1.09425,670 shs$39.15 million03/14/2025$1.17$1.14-2.56%$1.22$1.14376,931 shs$39.85 million Get the Latest News and Ratings for RAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/13/2025$1.25$1.17-6.40%$1.27$1.16436,168 shs$40.90 million03/12/2025$1.14$1.25+9.65%$1.30$1.13579,545 shs$43.70 million03/11/2025$1.07$1.14+6.54%$1.18$1.04669,643 shs$39.85 million03/10/2025$1.13$1.07-5.31%$1.17$1.06713,758 shs$37.41 million03/07/2025$1.12$1.13+0.89%$1.19$1.12386,792 shs$39.50 million03/06/2025$1.13$1.12-0.88%$1.20$1.09338,945 shs$39.15 million03/05/2025$1.10$1.13+2.73%$1.15$1.09413,703 shs$39.50 million03/04/2025$1.05$1.10+4.76%$1.14$1.02716,144 shs$38.45 million03/03/2025$1.14$1.05-7.89%$1.14$1.05339,739 shs$36.71 million02/28/2025$1.09$1.14+4.59%$1.14$1.07329,295 shs$39.85 million02/27/2025$1.17$1.09-6.84%$1.20$1.07714,067 shs$38.10 million Related Companies Nanobiotix Stock Chart Neoleukin Therapeutics Stock Chart Cidara Therapeutics Stock Chart Lyell Immunopharma Stock Chart scPharmaceuticals Stock Chart Inventiva Stock Chart C4 Therapeutics Stock Chart Compugen Stock Chart Eupraxia Pharmaceuticals Stock Chart Actuate Therapeutics Stock Chart Receive RAPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RAPT Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
